FI82695C - Foerfarande foer framstaellning av ett terapeutiskt anvaendbart 9-klor-5,6-dihydro-spiro/imidazolidin-5,7-7h -pyrido(1,2,3-de)kinoxalin/2,3,4-trionderivat. - Google Patents
Foerfarande foer framstaellning av ett terapeutiskt anvaendbart 9-klor-5,6-dihydro-spiro/imidazolidin-5,7-7h -pyrido(1,2,3-de)kinoxalin/2,3,4-trionderivat. Download PDFInfo
- Publication number
- FI82695C FI82695C FI861544A FI861544A FI82695C FI 82695 C FI82695 C FI 82695C FI 861544 A FI861544 A FI 861544A FI 861544 A FI861544 A FI 861544A FI 82695 C FI82695 C FI 82695C
- Authority
- FI
- Finland
- Prior art keywords
- conh
- formula
- con
- chloro
- imidazolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1984/001290 WO1986001107A1 (en) | 1984-08-14 | 1984-08-14 | Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making |
US8401290 | 1984-08-14 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI861544A FI861544A (fi) | 1986-04-11 |
FI861544A0 FI861544A0 (fi) | 1986-04-11 |
FI82695B FI82695B (fi) | 1990-12-31 |
FI82695C true FI82695C (fi) | 1991-04-10 |
Family
ID=22182231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI861544A FI82695C (fi) | 1984-08-14 | 1986-04-11 | Foerfarande foer framstaellning av ett terapeutiskt anvaendbart 9-klor-5,6-dihydro-spiro/imidazolidin-5,7-7h -pyrido(1,2,3-de)kinoxalin/2,3,4-trionderivat. |
Country Status (24)
Country | Link |
---|---|
US (1) | US4656169A (el) |
EP (1) | EP0173497B1 (el) |
JP (1) | JPS6147486A (el) |
KR (1) | KR870000624B1 (el) |
AT (1) | ATE46162T1 (el) |
AU (1) | AU553699B2 (el) |
CA (1) | CA1255304A (el) |
DD (1) | DD236529A5 (el) |
DE (1) | DE3572818D1 (el) |
DK (1) | DK366685A (el) |
ES (2) | ES8704495A1 (el) |
FI (1) | FI82695C (el) |
GR (1) | GR851968B (el) |
IE (1) | IE58123B1 (el) |
IL (1) | IL76076A0 (el) |
IN (2) | IN166581B (el) |
NO (1) | NO164101C (el) |
NZ (1) | NZ213085A (el) |
PH (1) | PH22910A (el) |
PL (2) | PL147875B1 (el) |
PT (1) | PT80940B (el) |
WO (1) | WO1986001107A1 (el) |
YU (1) | YU44894B (el) |
ZA (1) | ZA856102B (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
US5202339A (en) * | 1987-08-28 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
AU623676B2 (en) * | 1988-08-24 | 1992-05-21 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
TW202450B (el) * | 1991-06-26 | 1993-03-21 | Dainippon Pharmaceutical Co |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
US4193996A (en) * | 1979-04-04 | 1980-03-18 | Pfizer Inc. | Spiro-quinolone hydantoins |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1984
- 1984-08-14 WO PCT/US1984/001290 patent/WO1986001107A1/en active IP Right Grant
- 1984-08-14 US US06/854,588 patent/US4656169A/en not_active Expired - Fee Related
-
1985
- 1985-07-15 IN IN552/DEL/85A patent/IN166581B/en unknown
- 1985-08-08 EP EP85305636A patent/EP0173497B1/en not_active Expired
- 1985-08-08 DE DE8585305636T patent/DE3572818D1/de not_active Expired
- 1985-08-08 AT AT85305636T patent/ATE46162T1/de not_active IP Right Cessation
- 1985-08-12 ES ES546093A patent/ES8704495A1/es not_active Expired
- 1985-08-12 DD DD85279599A patent/DD236529A5/de not_active IP Right Cessation
- 1985-08-12 JP JP60177463A patent/JPS6147486A/ja active Granted
- 1985-08-12 CA CA000488544A patent/CA1255304A/en not_active Expired
- 1985-08-12 IL IL76076A patent/IL76076A0/xx not_active IP Right Cessation
- 1985-08-12 PT PT80940A patent/PT80940B/pt not_active IP Right Cessation
- 1985-08-12 GR GR851968A patent/GR851968B/el unknown
- 1985-08-13 AU AU46126/85A patent/AU553699B2/en not_active Ceased
- 1985-08-13 PL PL1985261413A patent/PL147875B1/pl unknown
- 1985-08-13 DK DK366685A patent/DK366685A/da not_active Application Discontinuation
- 1985-08-13 ZA ZA856102A patent/ZA856102B/xx unknown
- 1985-08-13 PL PL1985254960A patent/PL145221B1/pl unknown
- 1985-08-13 NZ NZ213085A patent/NZ213085A/en unknown
- 1985-08-13 IE IE199185A patent/IE58123B1/en not_active IP Right Cessation
- 1985-08-13 YU YU1290/85A patent/YU44894B/xx unknown
- 1985-08-13 KR KR1019850005822A patent/KR870000624B1/ko not_active IP Right Cessation
- 1985-08-14 PH PH32632A patent/PH22910A/en unknown
-
1986
- 1986-02-13 ES ES551963A patent/ES8801831A1/es not_active Expired
- 1986-04-11 FI FI861544A patent/FI82695C/fi not_active IP Right Cessation
- 1986-04-11 NO NO86861425A patent/NO164101C/no unknown
-
1987
- 1987-06-17 IN IN522/DEL/87A patent/IN166590B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1373219A1 (fr) | Thiohydantoines et leur utilisation dans le traitement du diabete | |
AU2004255191A1 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of Alzheimer's disease | |
EP1142885B1 (en) | 2-(n-cyanoimino)thiazolidin-4-one derivatives | |
JPH0242053A (ja) | アミノグアニジン誘導体およびそれらを有効成分として含有するメイラード反応阻害剤 | |
FI82695C (fi) | Foerfarande foer framstaellning av ett terapeutiskt anvaendbart 9-klor-5,6-dihydro-spiro/imidazolidin-5,7-7h -pyrido(1,2,3-de)kinoxalin/2,3,4-trionderivat. | |
US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
US4900739A (en) | Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents | |
US5654323A (en) | Heterocyclic compounds | |
AU638878B2 (en) | New benzoselenazolinone compounds, process for preparing these and pharmaceutical compositions containing them | |
HU194159B (en) | Process for preparing n- square brackets open 6-methoxy-5- /perfluoroalkyl/-1-naphtoyl square brackets closed -n-methylglycines and their thionaphtyl analogues and pharmaceuticals comprising such active substance | |
CA2049490A1 (en) | Pyrrolobenzimidazoles, imidazobenzoxazinones and imidazoquinolones, process for their preparation and their use and preparations containing the compounds | |
EP0143461B1 (en) | Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same | |
JP4658512B2 (ja) | クマリン誘導体及び該誘導体を含有するメイラード反応阻害剤 | |
US4612317A (en) | Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases | |
US4337265A (en) | Cyclohepta[b]pyrrole derivatives | |
EP0136143B1 (en) | Spiro-succinimides for treatment of diabetes complications | |
DE69101937T2 (de) | Antiallergische und antiinflammatorische Mittel auf der Basis von Benzoquinon. | |
US4663319A (en) | 3-(1,3-dithiol-2-ylidene)-2,4-dioxopyrrolidines, -piperidines, and -hexahydroazepines and use thereof against hepatic diseases | |
US4946858A (en) | Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents | |
EP0168181A1 (en) | Cyclic amides | |
FI80037B (fi) | Vid vaord av diabeteskomplikationer tillaempade spiroimidazoler. | |
JPS5976075A (ja) | ナフタレニルチアゾ−ル誘導体 | |
CN113651767A (zh) | 一种苯并异噁唑类杂环化合物及其制备方法和应用 | |
KR840001286B1 (ko) | 2-이미다졸린 유도체류의 제조방법 | |
IE920120A1 (en) | 2,4-DIOXO-PYRIDO[2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS¹AND SALTS THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: PFIZER INC. |